| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |